NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

I will work on a few more when I have time but here is a rough outline of one possible approach minus the detail that can only be added by them.

Option 1: Northwest Biotherapeutics Updates Data Communication Plan Ahead of the Society for Neurooncology

Today, Northwest Biotherapeutics updated their plans to release much anticipated data from their Clinical Trial in GBM. In accordance with prior commitments, the company will not be releasing data at this year’s Society for NO annual scientific meeting. The company remains committed to full public release with detailed review of statistical models and results of their 13 year long trial. While work continues to finalize a manuscript with journal editors, the company continues work on obtaining full marketing authorization in the US, European Union, UK, and Canada while they explore the requirements throughout Scandinavia and the rest of world.

“We remain committed to our approach to providing full disclosure of our results to our patients, providers, scientists and investors simultaneously through journal publication in a highly reputable medical journal. While SNO has been a great venue for both our research team of investigators and our own efforts in past years, we are steadfast in our desire to broadcast our groundbreaking trial very soon through press.” Commented LP, CEO/CFO Northwest Biotherapeutics. “ We thank our investors, our research partners, in particular Dr. Linda Liau and Keymours Askan for their hard work in getting us to this moment in history, and of course we thank our patients for whom we all strive to serve.”